Literature DB >> 32113991

Trend and forecasting of the COVID-19 outbreak in China.

Qiang Li1, Wei Feng2, Ying-Hui Quan3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32113991      PMCID: PMC7154515          DOI: 10.1016/j.jinf.2020.02.014

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.

Dear editors,

Very recently, a letter in Journal of Infection reported the outbreak of the novel cornonavirus from Dec. 2019 in China, especially in Hubei province. This novel cornonavirus may originate from the bat, is just named as the COVID-19 by the World Health Organization (WHO). The COVID-19 outbroke from Wuhan, the capital of Hubei province, has spread to other provinces of China and even other countries. Strong human-to-human transmission is established. Until Feb. 11, 2020, there have been 44653 cases of COVID-19 infections confirmed in mainland China, including 1113 deaths. To prevent and control the spread of the epidemic, many strategies are needed. Predicting the trend of the epidemic are quite important to the allocation of medical resources, the arrangement of production activities, and even the domestic economic development all over China. Therefore, it is very urgent to use the latest data to establish an efficient and highly suitable epidemic analysis and prediction model according to the actual situation, and then to give reliable predictions, which could provide an important reference for the government to formulate emergency macroeconomic decisions and medical resources allocation. Recently, the susceptible-exposed-infectious-recovered (SEIR) or other similar models 6, 7 are used to forecast the potential domestic and international spread of this COVID-19 epidemic with parameters estimated from other sources.The real situation could be much more complicated and changing all the time. Especially, with the implementation of the Chinese government’s multiple epidemic control policies, the control of nationwide epidemic has become obvious. However, the medical supplies in Hubei will still affect the implementation of national policies. In this letter, we present the current situation of the epidemic, predict the ongoing trend with data driven analysis, and estimate the outbreak size of the COVID-19 in both Hubei and other areas in mainland China. The data of the epidemic are listed in Table 1 and also graphically shown in Fig. 1 , in which “China” is used to denote the mainland China, and “Other” mainland China other than Hubei province. The data includes the daily confirmed(suspected) infections, totally confirmed(suspected) infections, daily deaths, and total deaths from Jan. 20, to Feb. 11, 2020, reported by the National Health Commission of the Republic of China (NHC),, and Health Commission of Hubei Province (HCH). Jan. 20, 2020, containing all the cases reported from 0 to 24, is the zeroth day in this letter, and then others are implied. The total number of suspected cases reaches the peak value on the 19th day (Feb. 8), and then drops rapidly. Notice that, until Feb. 11, 2020, almost all the cases of deaths (1068/1113, 96%,) locates in Hubei province, which reveals the epidemic in Hubei is much more serious than that in the other areas of China. On the hand, it states the strict quarantine and limitation on population mobility have effectively prevented outbreaks in other provinces of China.
Table 1

The data of epidemic caused by the COVID-19 pneumonia in the mainland China and Hubei, including (A) daily infections, (B) daily deaths, (C) total infections, (D) total deaths, (E) daily and (F) total suspected cases.

DateChina
Hubei
ABCDEFABCD
2020/1/20772291627547222706
2020/1/2114934409263710533759
2020/1/2213185711725739369844417
2020/1/232598830256801072105754924
2020/1/2444416128741111819651801572939
2020/1/25688151975561309268432313105252
2020/1/26769242744803806579437124142376
2020/1/271771264515106207769731291242714100
2020/1/28145926597413232489239840253554125
2020/1/291737387711170414812,1671032374586162
2020/1/301982439692213481215,2381220425806204
2020/1/3121024611,791259501917,9881347457153249
2020/2/125904514,380304456219,5441921459074294
2020/2/228295717,205361517321,55821035611,177350
2020/2/332356420,438425507223,21423456413,522414
2020/2/438876524,324490397123,26031566516,678479
2020/2/536947328,018563532824,70229877019,665549
2020/2/631437331,161636483326,35924476922,112618
2020/2/733998634,546722421427,65728418124,953699
2020/2/826568937,198811391628,94221478127,100780
2020/2/930629740,171908400823,58926189129,631871
2020/2/10247810842,6381016353621,675209710331,728974
2020/2/1120159744,6531113334216,06716389433,3661068
Fig. 1

Varies of the COVID-19 epidemic (Jan. 20–Feb. 11, 2020) in China, with (a) total and (b) daily suspected and confirmed cases, (c) total and (d) daily deaths, (e) death rate, and (f) deaths in China other than Hubei.

The data of epidemic caused by the COVID-19 pneumonia in the mainland China and Hubei, including (A) daily infections, (B) daily deaths, (C) total infections, (D) total deaths, (E) daily and (F) total suspected cases. Varies of the COVID-19 epidemic (Jan. 20–Feb. 11, 2020) in China, with (a) total and (b) daily suspected and confirmed cases, (c) total and (d) daily deaths, (e) death rate, and (f) deaths in China other than Hubei. We use function to describe the data of daily infections and deaths in Hubei, where with t denoting the day, and t T representing the turning point; A and k are the parameters and determined by the data together with t T. The cumulative data of infections or deaths are obtained by the integration over h(t). For the epidemic in the other areas of China, the data of infections shows an asymmetric character, and then will be described as where ; the parameters B, k 1, and k 2 together with t T, are then determined by fitting to the data. Fig. 2 shows the fit and trend predictions to the total infections and deaths in Hubei and China other than Hubei. The extracted turning point of the infections in Hubei is the 17th day, namely, Feb. 6, 2020. The epidemic in Hubei is predicted to end after Mar. 10, 2020. We estimated that the epidemic is to end up with a total of 39, 000 infections in Hubei, not including the clinically diagnosed cases since Feb. 12, which may enlarge the prediction by 1.4 times. With considered data, namely, data from Jan. 20 to Feb. 11, the average errors are bout 166 and 190 for the fits to describe the daily and cumulative infections in Hubei, respectively, corresponding to 8.6% and 1.6% for the average relative errors, respectively.
Fig. 2

Data (Jan. 20–Feb. 11, 2020) and fits of the infections and deaths in China; the black circle denotes the data, and the dotted line the predicted trend; the turning points of daily infections and deaths in Hubei are predicted to be Feb. 6, and Feb. 12, 2020, respectively, and Feb. 1 for daily infections in China other than Hubei.

Data (Jan. 20–Feb. 11, 2020) and fits of the infections and deaths in China; the black circle denotes the data, and the dotted line the predicted trend; the turning points of daily infections and deaths in Hubei are predicted to be Feb. 6, and Feb. 12, 2020, respectively, and Feb. 1 for daily infections in China other than Hubei. Fig. 2 (b) and (e) shows the estimations of the total and daily deaths in Hubei. The predicted turning point is Feb. 12, 2020. The total deaths is estimated to be 2250. Notice the distribution of the daily deaths is delayed about 5∼6 days compared with the that of the daily infections. The average errors are bout 4 and 22 for the model to describe the daily and cumulative death numbers, respectively, corresponding to the relative errors 8.6% and 6.2%, respectively. The numbers of the daily and total infections in China other than Hubei are showed in Fig. 2(c) and 2(f), respectively. The extracted turning point is Feb. 1, 2020 and the epidemic is expected to end on the 45th day, namely, on Mar. 5, 2020. The estimated number of cumulative infections is about 12,600 in China other than Hubei. With the data in the considered period, the average errors are bout 41 and 58 for this model to describe the daily and total cumulative infections, and the corresponding relative errors are about 8.4% and 1.2%, respectively. Due to the minority of the statistical data in deaths of China other than Hubei (45 until Feb. 11, 2020, see Fig. 1(f)), we did not parameterize this data, and hence did not give a trend prediction. The COVID-19 epidemic in China is predicted to end after Mar. 20, 2020, and cause 52,000–68,000 infections and about 2400 deaths. However, the data trends show that the quick and active strategies to reduce human exposure taken in China, such as limitation on population mobility and interpersonal contact rates, strict quarantine on migrants, have already had good impacts on control of the epidemic. Now the outbreak and deaths of the COVID-19 epidemic are mainly in Hubei province. After this letter has been written, the Hubei reported 14,840 confirmed infections (including 13,332 clinically diagnosed cases) on Feb. 12, 2020, which is almost 9 times greater than the data of the previous day. The huge fluctuation is due to the changing of diagnostic criteria in Hubei. And this clinical criteria taken in Hubei is expected to play an active and important role in controlling the outbreak and death rate.

Declaration of Competing Interest

The authors declare no conflict of interest.
  7 in total

1.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

2.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

3.  Emergence of SARS-like coronavirus poses new challenge in China.

Authors:  Ruichen Wang; Xu Zhang; David M Irwin; Yongyi Shen
Journal:  J Infect       Date:  2020-01-30       Impact factor: 6.072

4.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

5.  What to do next to control the 2019-nCoV epidemic?

Authors:  Fu-Sheng Wang; Chao Zhang
Journal:  Lancet       Date:  2020-02-08       Impact factor: 79.321

6.  An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov).

Authors:  Biao Tang; Nicola Luigi Bragazzi; Qian Li; Sanyi Tang; Yanni Xiao; Jianhong Wu
Journal:  Infect Dis Model       Date:  2020-02-11

Review 7.  Bat origin of a new human coronavirus: there and back again.

Authors:  Xiang Li; Yuhe Song; Gary Wong; Jie Cui
Journal:  Sci China Life Sci       Date:  2020-02-09       Impact factor: 6.038

  7 in total
  34 in total

Review 1.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

2.  Genetic characterization of chikungunya virus isolates from Aedes aegypti mosquitoes collected during a recent outbreak in Bangkok, Thailand.

Authors:  Proawpilart Intayot; Atchara Phumee; Kanyarat Kraivichian; Sriwatapron Sor-Suwan; Rungfar Boonserm; Padet Siriyasatien
Journal:  Arch Virol       Date:  2021-10-08       Impact factor: 2.574

3.  Multicriteria group decision making via generalized trapezoidal intuitionistic fuzzy number-based novel similarity measure and its application to diverse COVID-19 scenarios.

Authors:  Palash Dutta; Gourangajit Borah
Journal:  Artif Intell Rev       Date:  2022-09-07       Impact factor: 9.588

4.  Estimating the Prevalence and Mortality of Coronavirus Disease 2019 (COVID-19) in the USA, the UK, Russia, and India.

Authors:  Yongbin Wang; Chunjie Xu; Sanqiao Yao; Yingzheng Zhao; Yuchun Li; Lei Wang; Xiangmei Zhao
Journal:  Infect Drug Resist       Date:  2020-09-29       Impact factor: 4.003

5.  Accurate detection of Covid-19 patients based on Feature Correlated Naïve Bayes (FCNB) classification strategy.

Authors:  Nehal A Mansour; Ahmed I Saleh; Mahmoud Badawy; Hesham A Ali
Journal:  J Ambient Intell Humaniz Comput       Date:  2021-01-15

6.  Epidemiological characteristics of COVID-19: a systematic review and meta-analysis.

Authors:  Malahat Khalili; Mohammad Karamouzian; Naser Nasiri; Sara Javadi; Ali Mirzazadeh; Hamid Sharifi
Journal:  Epidemiol Infect       Date:  2020-06-29       Impact factor: 2.451

7.  Estimation of COVID-19 spread curves integrating global data and borrowing information.

Authors:  Se Yoon Lee; Bowen Lei; Bani Mallick
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

8.  Predicting the Epidemiological Outbreak of the Coronavirus Disease 2019 (COVID-19) in Saudi Arabia.

Authors:  Dabiah Alboaneen; Bernardi Pranggono; Dhahi Alshammari; Nourah Alqahtani; Raja Alyaffer
Journal:  Int J Environ Res Public Health       Date:  2020-06-25       Impact factor: 3.390

Review 9.  Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.

Authors:  Bogna Grygiel-Górniak
Journal:  Clin Rheumatol       Date:  2021-07-03       Impact factor: 3.650

10.  Stochastic modelling for predicting COVID-19 prevalence in East Africa Countries.

Authors:  Rediat Takele
Journal:  Infect Dis Model       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.